Evidence map›Paper›PMID 31386072›Full record

ArticleNeuro-oncology practice2016

Carers of patients with high-grade glioma report high levels of distress, unmet needs, and psychological morbidity during patient chemoradiotherapy.

Anne Long, Georgia K B Halkett, Elizabeth A Lobb, Thérèse Shaw, Elizabeth Hovey, Anna K Nowak

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Neuro-oncology practice, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Benefits of supportive strategies for carers of people with high-grade glioma: a systematic review : Strategies for addressing the needs of high-grade glioma carers.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Article
  10. Neuro-oncology practice · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The impact of a primary brain tumor diagnosis on caregivers: Insights from the patients' perspective.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anne LongDepartment of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia (A.L., A.K.N.); School of Nursing, Midwifery and Paramedicine, Faculty of Health Sciences, Curtin University, Bentley, Western Australia (G.K.B.H.); Calvary Health Care Kogarah and Cunningham Centre for Palliative Care, Sydney, New South Wales (E.A.L.); School of Medicine, The University of Notre Dame, Sydney, New South Wales (E.A.L.); Telethon Kids Institute, Perth, Western Australia (T.S.); Department of Medical Oncology, Prince of Wales Hospital, Sydney, New South Wales (E.H.); Department of Medicine, University of New South Wales, Sydney, New South Wales (E.H.); School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia (A.K.N.).
Georgia K B HalkettDepartment of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia (A.L., A.K.N.); School of Nursing, Midwifery and Paramedicine, Faculty of Health Sciences, Curtin University, Bentley, Western Australia (G.K.B.H.); Calvary Health Care Kogarah and Cunningham Centre for Palliative Care, Sydney, New South Wales (E.A.L.); School of Medicine, The University of Notre Dame, Sydney, New South Wales (E.A.L.); Telethon Kids Institute, Perth, Western Australia (T.S.); Department of Medical Oncology, Prince of Wales Hospital, Sydney, New South Wales (E.H.); Department of Medicine, University of New South Wales, Sydney, New South Wales (E.H.); School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia (A.K.N.).
Elizabeth A LobbDepartment of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia (A.L., A.K.N.); School of Nursing, Midwifery and Paramedicine, Faculty of Health Sciences, Curtin University, Bentley, Western Australia (G.K.B.H.); Calvary Health Care Kogarah and Cunningham Centre for Palliative Care, Sydney, New South Wales (E.A.L.); School of Medicine, The University of Notre Dame, Sydney, New South Wales (E.A.L.); Telethon Kids Institute, Perth, Western Australia (T.S.); Department of Medical Oncology, Prince of Wales Hospital, Sydney, New South Wales (E.H.); Department of Medicine, University of New South Wales, Sydney, New South Wales (E.H.); School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia (A.K.N.).
Thérèse ShawDepartment of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia (A.L., A.K.N.); School of Nursing, Midwifery and Paramedicine, Faculty of Health Sciences, Curtin University, Bentley, Western Australia (G.K.B.H.); Calvary Health Care Kogarah and Cunningham Centre for Palliative Care, Sydney, New South Wales (E.A.L.); School of Medicine, The University of Notre Dame, Sydney, New South Wales (E.A.L.); Telethon Kids Institute, Perth, Western Australia (T.S.); Department of Medical Oncology, Prince of Wales Hospital, Sydney, New South Wales (E.H.); Department of Medicine, University of New South Wales, Sydney, New South Wales (E.H.); School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia (A.K.N.).
Elizabeth HoveyDepartment of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia (A.L., A.K.N.); School of Nursing, Midwifery and Paramedicine, Faculty of Health Sciences, Curtin University, Bentley, Western Australia (G.K.B.H.); Calvary Health Care Kogarah and Cunningham Centre for Palliative Care, Sydney, New South Wales (E.A.L.); School of Medicine, The University of Notre Dame, Sydney, New South Wales (E.A.L.); Telethon Kids Institute, Perth, Western Australia (T.S.); Department of Medical Oncology, Prince of Wales Hospital, Sydney, New South Wales (E.H.); Department of Medicine, University of New South Wales, Sydney, New South Wales (E.H.); School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia (A.K.N.).
Anna K NowakDepartment of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Western Australia (A.L., A.K.N.); School of Nursing, Midwifery and Paramedicine, Faculty of Health Sciences, Curtin University, Bentley, Western Australia (G.K.B.H.); Calvary Health Care Kogarah and Cunningham Centre for Palliative Care, Sydney, New South Wales (E.A.L.); School of Medicine, The University of Notre Dame, Sydney, New South Wales (E.A.L.); Telethon Kids Institute, Perth, Western Australia (T.S.); Department of Medical Oncology, Prince of Wales Hospital, Sydney, New South Wales (E.H.); Department of Medicine, University of New South Wales, Sydney, New South Wales (E.H.); School of Medicine and Pharmacology, University of Western Australia, Nedlands, Western Australia (A.K.N.).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFew studies have explored the unmet needs of carers of people with high-grade glioma. We aimed to determine carers' levels of distress during treatment, understand their support needs and explore predictors of distress.

methodsCarers of people with high-grade glioma undergoing chemoradiotherapy were recruited to this prospective, longitudinal cohort study. Carers completed the validated Supportive Care Needs Survey, Brain Tumour Specific Supportive Care Needs Scale, Distress Thermometer (DT), and General Health Questionnaire (GHQ-12). Questionnaires were administered during patients' chemoradiotherapy and 3 and 6 months later.

resultsWe recruited 118 carers who were mainly female (72%) and caring for spouse (82%). The mean age was 53 years (SD = 13.6; range, 21-89). Thirty-one percent of carers reported moderate distress (DT score 5-6/10) and 31% reported extreme distress (score 7-10/10) during combined chemoradiotherapy. Carer distress was associated with adverse GHQ scores (

conclusionCarers reported substantial distress, and high distress levels were correlated with greater psychological impact and increased self-reporting of unmet needs. Future research should focus on interventions that aid in reducing carer distress.

Indexed as

carers’ needscarer surveydistresshigh-grade gliomapsychological impact

Identifiers

PMID31386072
PMCPMC6668264

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.